Additionally, exosomes are regarded as extracellular nanovesicles [131], and are capable of transmitting specific oncogenic RNAs to promote NSCLC progression and drug resistance by upregulating the expression of METTL3 [132]. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.